CBDBY Statistics
Total Valuation
CBDBY has a market cap or net worth of 268.82 million. The enterprise value is 1.48 billion.
| Market Cap | 268.82M |
| Enterprise Value | 1.48B |
Important Dates
The last earnings date was Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +85.27% |
| Shares Change (QoQ) | -45.66% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 278.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | 0.56 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | 2.73 |
| P/OCF Ratio | 1.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.97, with an EV/FCF ratio of 15.01.
| EV / Earnings | -4.43 |
| EV / Sales | 0.44 |
| EV / EBITDA | 7.97 |
| EV / EBIT | 43.69 |
| EV / FCF | 15.01 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 3.26.
| Current Ratio | 0.98 |
| Quick Ratio | 0.53 |
| Debt / Equity | 3.26 |
| Debt / EBITDA | 9.15 |
| Debt / FCF | 15.99 |
| Interest Coverage | 0.12 |
Financial Efficiency
Return on equity (ROE) is -36.32% and return on invested capital (ROIC) is 0.61%.
| Return on Equity (ROE) | -36.32% |
| Return on Assets (ROA) | 0.39% |
| Return on Invested Capital (ROIC) | 0.61% |
| Return on Capital Employed (ROCE) | 0.94% |
| Revenue Per Employee | 30,080 |
| Profits Per Employee | -3,038 |
| Employee Count | 110,000 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 6.87 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.39% in the last 52 weeks. The beta is 1.35, so CBDBY's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -16.39% |
| 50-Day Moving Average | 0.51 |
| 200-Day Moving Average | 0.46 |
| Relative Strength Index (RSI) | 40.92 |
| Average Volume (20 Days) | 57,002 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CBDBY had revenue of 3.31 billion and -334.18 million in losses. Loss per share was -0.72.
| Revenue | 3.31B |
| Gross Profit | 914.28M |
| Operating Income | 22.15M |
| Pretax Income | -268.60M |
| Net Income | -334.18M |
| EBITDA | 92.09M |
| EBIT | 22.15M |
| Loss Per Share | -0.72 |
Balance Sheet
The company has 379.70 million in cash and 1.58 billion in debt, giving a net cash position of -1.20 billion.
| Cash & Cash Equivalents | 379.70M |
| Total Debt | 1.58B |
| Net Cash | -1.20B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 483.82M |
| Book Value Per Share | 1.81 |
| Working Capital | -23.20M |
Cash Flow
In the last 12 months, operating cash flow was 210.87 million and capital expenditures -112.32 million, giving a free cash flow of 98.54 million.
| Operating Cash Flow | 210.87M |
| Capital Expenditures | -112.32M |
| Free Cash Flow | 98.54M |
| FCF Per Share | n/a |
Margins
Gross margin is 27.63%, with operating and profit margins of 0.67% and -10.10%.
| Gross Margin | 27.63% |
| Operating Margin | 0.67% |
| Pretax Margin | -8.12% |
| Profit Margin | -10.10% |
| EBITDA Margin | 2.78% |
| EBIT Margin | 0.67% |
| FCF Margin | 2.98% |
Dividends & Yields
CBDBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -85.27% |
| Shareholder Yield | -85.27% |
| Earnings Yield | -124.31% |
| FCF Yield | 36.66% |
Stock Splits
The last stock split was on October 18, 2010. It was a forward split with a ratio of 2.
| Last Split Date | Oct 18, 2010 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |